GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MabCure MBCI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2011

Revenue

$500,000

FY2011FY2011

Net income

−$12.5m

FY2011FY2011

Free cash flow

−$62,652

FY2011FY2011

Shareholders' equity

$3.9m

FY2011FY2011

Income statement

Fiscal years

FY2011
Revenue$500,000
Gross profit$500,000
Research and development$390,640
Operating income−$709,745
Net income−$12.5m
Diluted earnings per share-0.19

Balance sheet

At each fiscal year end

FY2011
Total assets$4.8m
Cash and short-term investments$146,436
Total liabilities$935,148
Debt$261,164
Shareholders' equity$3.9m
Shares outstanding64m

Cash flow

Fiscal years

FY2011
Cash from operations−$61,387
Capital spending−$1,265
Free cash flow−$62,652

Latest quarters

By quarter end

Dec 2011Sept 2011Jun 2011Mar 2011Dec 2010Sept 2010Jun 2010Mar 2010
Revenue$500,000———————
Gross profit$500,000———————
Operating income$226,562−$266,625−$318,913−$349,942−$240,968−$268,366−$227,037−$291,563
Net income−$11.2m−$284,513−$513,536−$457,655−$636,562−$269,571−$227,935−$298,167
Diluted earnings per share-0.18-0.00-0.01-0.01-0.01-0.00-0.00-0.00
Total assets$4.8m$16.1m$16.1m$16.2m$16.2m$18.7m$18.9m$19.1m
Cash and short-term investments$146,436$13,923$34,734$2,228$3,415$47,253$243,802$439,027
Debt$261,164$271,725$267,420$47,468$169,566$94,165$90,018$92,781
Shareholders' equity$3.9m$15.0m$15.1m$15.3m$15.7m$18.4m$18.6m$18.9m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income9.8%181.7%—
Net income186.1%399.6%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return200%400%50%483%676615266%12763181%142%6222%18001%2563%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-for-1 split · 26 Nov 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.